BIVI Market Cap History
Below is a table of the BIVI market cap history going back to 9/18/2020:

Date BIVI Market Cap
9/18/2020134.55M
11/3/2020113.07M
1/15/2021527.70M
5/7/2021214.26M
8/27/2021196.18M

Also see: BIVI Shares Outstanding History
and BIVI YTD Return
BIVI Historical Market Cap:
+48.74% CAGR
BIVI Historical Market Cap: +48.74% CAGR

Mouse over chart for data details
9/18/202011/3/20201/15/20215/7/20218/27/2021
BioVie is a clinical-stage company developing drug therapies to overcome unmet medical needs in chronic debilitating conditions. In liver disease, Co.'s orphan drug candidate, BIV201 (continuous infusion terlipressin), is being developed as a future treatment option for patients suffering from ascites and other life-threatening complications of liver cirrhosis caused by nonalcoholic steatohepatitis, hepatitis, and alcoholism. In neurodegenerative disease, Co.'s product candidate, NE3107, is an orally administered small molecule that is thought to inhibit inflammation-driven insulin resistance and primary pathological inflammatory cascades with a mechanism of action. We show 5 historical shares outstanding datapoints in our BIVI shares outstanding history coverage, used to compute BIVI market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BIVI market cap history over the course of time is important for investors interested in comparing BIVI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BIVI versus a peer is one thing; comparing BIVI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BIVI can fluctuate over the course of history. With this page we aim to empower investors researching BIVI by allowing them to research the BIVI market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BIVI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BioVie (BIVI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BKD Market Cap History
BLCM Market Cap History
BLFS Market Cap History
BLI Market Cap History
BLPH Market Cap History
BLRX Market Cap History
BLUE Market Cap History
BMEA Market Cap History
BMRA Market Cap History
BMRN Market Cap History
More Healthcare companies »

 

BIVI Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.